Gmail Calendar Docs Reader La Web Más »
Grupos visitados recientemente | Ayuda | Acceder
Página principal de Grupos de Google
* William Engdahl: Nano Particles in H1N1 Swine Flu Vaccines *
En este grupo hay demasiados temas que deben mostrarse primero. Para que este aparezca al principio de la lista, debes descartar esta opción para alguno de los anteriores.
Error al procesar tu solicitud. Por favor, inténtalo de nuevo.
marcar
  1 mensaje - Ocultar todos  -  Traducir todo al Traducido (ver todos los originales)
El grupo al cual envías entradas es un grupo Usenet. Si envías mensajes a este grupo, cualquier usuario de Internet podrá ver tu dirección de correo electrónico
Tu respuesta no se ha enviado.
Tu entrada se ha publicado correctamente.
 
De:
Para:
Cc:
Seguimiento:
Añadir Cc | Añadir seguimiento | Editar asunto
Asunto:
Validación:
Con fines de verificación, escribe los caracteres que veas en la imagen siguiente o los números que escuches haciendo clic en el icono de accesibilidad. Escucha y escribe los números que oyes.
 
Richard Moore  
Ver perfil   Traducir al Traducido (ver original)
 Más opciones 4 nov, 10:56
Grupos de noticias: misc.activism.progressive
Seguimiento: alt.activism.d
De: Richard Moore <r...@quaylargo.com>
Fecha: Wed, 4 Nov 2009 10:56:46 -0600 (CST)
Local: Mié 4 nov 2009 10:56
Asunto: * William Engdahl: Nano Particles in H1N1 Swine Flu Vaccines *
http://globalresearch.ca/index.php?context=va&aid=15092

Nano Particles used in Untested H1N1 Swine Flu Vaccines Part III:
Its the vaccines, Stupid!

By F. William Engdahl

Global Research<http://www.globalresearch.ca/>, September 13, 2009

Vaccines which have been approved by the responsible government
authorities for vaccination against the alleged H1N1 Influenza A
Swine Flu have been found to contain nano particles. Vaccine makers
have been experimenting with nanoparticles as a way to turbo charge
vaccines for several years. Now it has come out that the vaccines
approved for use in Germany and other European countries contain
nanoparticles in a form that reportedly attacks healthy cells and
can be deadly.

In 2007 researchers at the Ecole Polytechnique Fidirale de Lausanne
(EPFL) announced in an article in the journal, Nature Biotechnology,
that they had developed  a nanoparticle that can deliver vaccines
more effectively, with fewer side effects, and at a fraction of the
cost of current vaccine technologies. The article went on to describe
the effects of their breakthrough: At a mere 25 nanometers, these
particles are so tiny that once injected, they flow through the
skins extracellular matrix, making a beeline to the lymph nodes.
Within minutes, theyve reached a concentration of DCs thousands of
times greater than in the skin. The immune response can then be
extremely strong and effective. 1

There is only one small problem with vaccines containing nanoparticlesthey
can be deadly and at the least cause severe irreparable health
damage.

Nanoparticles, promoted in the mass media as the new wonder revolution
of science, are particles that have been produced vastly smaller
than deadly asbestos particles which caused severe lung damage and
death before being outlawed. Particles at a nano size, (nm =
0,000000001 Meter) fuse together with the membranes of our body
cell membranes and, according to recent studies in China and Japan,
continuously destroy cells once introduced into the body.

Once they interact with the bodys cellular structure, they cannot
be removed.

Modern medicine euphemistically terms the phenomenon, a continuing
infectious reaction.

Since the asbestos scandal, it has been established that particles
in size a millionth of a meter, because of their enormous attractive
force, penetrate all cells, destroying all those they come into
contact with. Nanoparticles are far smaller than asbestos fibers.

Beijing Tests confirm deadly effects on humans The fact that WHO,
the European Medicines Evaluation Agency, the German Robert Koch
Institute and other health bodies today would permit the population
to be injected with largely untested novel vaccines containing
nanoparticles says more about the powerful pharma lobby in Euiropean
politics than it does about the sanity or moral integrity of the
civil servants responsible for health of the general public.

The September 2009 issue of the respected European Respiratory
Journal, made public on 19 August, and available since 21 August
online, contains a peer-reviewed article with the title, Exposure
to nanoparticles is related to pleural effusion, pulmonary fibrosis
and granuloma.

The article describes tests carried out in 2008 at the elite Beijing
Chaoyang Hospital on seven young women. All seven, ages 18-47 had
been exposed to nanoparticles for 513 months in their common
workplace. All were admitted to the hospital with shortness of
breath and pleural effusions, or excessive fluids surrounding the
lungs, inhibiting breathing. None of the seven had ever smoked and
none were in any special risk group. Doctors carefully tested for
every possibility and confirmed that the lung problems had a common
originregular inhalation of nanoparticles in their factory. They
had been exposed to Polyacrylat nanoparticles.

The tests confirmed the nanoparticles had set off a super-meltdown
reaction in the patients. Despite all heroic efforts of doctors,
two of the seven died from the lung complications. 2 In their report,
the scientists concluded something so alarming it is necessary to
quote at length:

Immunological tests, examinations of bacteriology, virology and
tumour markers, bronchoscopy, internal thoracoscopy and video-assisted
thoracic surgery were performed. Surveys of the workplace, clinical
observations and examinations of the patients were conducted.
Polyacrylate, consisting of nanoparticles, was confirmed in the
workplace. Pathological examinations of patients' lung tissue
displayed nonspecific pulmonary inflammation, pulmonary fibrosis
and foreign-body granulomas of pleura. Using transmission electron
microscopy, nanoparticles were observed to lodge in the cytoplasm
and caryoplasm of pulmonary epithelial and mesothelial cells, but
are also located in the chest fluid. These cases arouse concern
that long-term exposure to some nanoparticles without protective
measures may be related to serious damage to human lungs.3 To date
Animal studies and in vitro experiments show that nanoparticles can
result in lung damage and other toxicity in animals, but no reports
on the clinical toxicity in humans due to nanoparticles prior to
the Beijing study had been made.

The Beijing Chaoyang Hospital study has now conclusively confirmed
that nanoparticles cause lung damage and other toxicity in humans
as well. At this point in time, when two of the approved vaccines
planned to be mass distributed in Germany and elsewhere contain
nanoparticles, failure of the relevant responsible public health
and epidemiology officials to order an immediate emergency freeze
on distribution of any vaccine containing nanoparticles can only
be considered tantamount to criminal negligence.

Hopefully the responsible authorities will react in time to avert
a possible human health catastrophe orders of magnitude worse than
the worst case of Swine Flu reported to date.

F. William Engdahl is author of Full Spectrum Dominance: Totalitarian
Democracy in the New World Order. He may be reached via his website,
www.engdahl.oilgeopolitics.net<http://www.engdahl.oilgeopolitics.net/>

Notes:

1 EPFL, Bioengineering researchers from the EPFL in Lausanne,
Switzerland, have developed and patented a nanoparticle that can
deliver vaccines more effectively, with fewer side effects, and at
a fraction of the cost of current vaccine technologies, accessed
in
www.azonano.com/nanotechnology%20news.asp?catid=13<http://www.azonano.com/nan
otechnology%20news.asp?catid=13>.

2  Song Y, Li X, Du X, Exposure to nanoparticles is related to
pleural effusion, pulmonary fibrosis and granuloma, European
Respiratory Journal, 9/2009, 34(3): 559-567.

3 Ibid.

________________________________

Disclaimer: The views expressed in this article are the sole
responsibility of the author and do not necessarily reflect those
of the Centre for Research on Globalization. The contents of this
article are of sole responsibility of the author(s). The Centre for
Research on Globalization will not be responsible or liable for any
inaccurate or incorrect statements contained in this article.

To become a Member of Global
Research<http://globalresearch.ca/index.php?context=section§ionName=membe
rship>

The CRG grants permission to cross-post original Global Research
articles on community internet sites as long as the text & title
are not modified. The source and the author's copyright must be
displayed. For publication of Global Research articles in print or
other forms including commercial internet sites, contact:
crgedi...@yahoo.com <mailto:crgedi...@yahoo.com>

www.globalresearch.ca<http://globalresearch.ca/www.globalresearch.ca>
contains copyrighted material the use of which has not always been
specifically authorized by the copyright owner. We are making such
material available to our readers under the provisions of "fair
use" in an effort to advance a better understanding of political,
economic and social issues. The material on this site is distributed
without profit to those who have expressed a prior interest in
receiving it for research and educational purposes. If you wish to
use copyrighted material for purposes other than "fair use" you
must request permission from the copyright owner.

For media inquiries: crgedi...@yahoo.com<mailto:crgedi...@yahoo.com>

Copyright F. William Engdahl, Global Research, 2009

The url address of this article is:

www.globalresearch.ca/PrintArticle.php?articleId=15092<http://www.globalresea
rch.ca/PrintArticle.php?articleId=15092>

________________________________

Copyright 2005-2007 GlobalResearch.ca Web site engine by Polygraphx
Multimedia<http://www.polygraphx.com/> ) Copyright 2005-2007

___________________________ subscribe mailto:

newslog+subscribe@googlegroups.com<mailto:newslog+subscribe@googlegroups.co m>

websites:

http://www.governourselves.org/ http://escapingthematrix.org/
http://thecreditbankdevelopmentmodel.blogspot.com/ http://cyberjournal.org

archives:

http://groups.google.com/group/newslog/topics
http://groups.google.com/group/cyberjournal/topics

Moderator: r...@quaylargo.com<mailto:r...@quaylargo.com>  (comments
welcome)

__._,_.___

Your email settings: Individual Email|Traditional Change settings
via the
Web<http://groups.yahoo.com/group/newslog/join;_ylc=X3oDMTJnaHEzNTJvBF9TA...
Dc2NTkwBGdycElkAzIwMTUzOTc2BGdycHNwSWQDMTcwNTA2MDQ3MQRzZWMDZnRyBHNsawNzdG5n cw
RzdGltZQMxMjU3MzUyODA3> (Yahoo! ID required) Change settings via
email: Switch delivery to Daily
Digest<mailto:newslog-dig...@yahoogroups.com?subject=Email%20Delivery:%20Dige
st> | Switch to Fully
Featured<mailto:newslog-fullfeatu...@yahoogroups.com?subject=Change%20Deliver
y%20Format:%20Fully%20Featured> Visit Your Group
<http://groups.yahoo.com/group/newslog;_ylc=X3oDMTJldnNzZTRwBF9TAzk3ND...
GdycElkAzIwMTUzOTc2BGdycHNwSWQDMTcwNTA2MDQ3MQRzZWMDZnRyBHNsawNocGYEc3RpbWUD MT
I1NzM1MjgwNw--> | Yahoo! Groups Terms of Use
<http://docs.yahoo.com/info/terms/> | Unsubscribe
<mailto:newslog-unsubscr...@yahoogroups.com?subject=Unsubscribe>

__,_._,___


    Responder    Responder al autor    Reenviar  
Debes registrarte antes de enviar mensajes.
Para enviar una entrada, antes deberás formar parte del grupo.
Antes de enviar entradas, actualiza tu alias en la configuración de la suscripción.
No dispones del permiso necesario para enviar entradas.
Fin de los mensajes
« Volver a “Debates” « Tema más reciente     Tema anterior »

Crear un grupo - Grupos de Google - Página principal de Google - Condiciones del servicio - Política de privacidad
©2009 Google